US 11021696
Nuclease-mediated regulation of gene expression
granted A61KA61K35/12A61K35/28
Quick answer
US patent 11021696 (Nuclease-mediated regulation of gene expression) held by Sangamo Therapeutics, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K35/12, A61K35/28, A61K38/465, A61K48/00